OBLIQUE THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Apr 2023)
What this means for you
This application is over — abandoned 03 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88178266
- Mark type
- Stylized text
- Filed
- 01 Nov 2018
- Published for opposition
- 07 Jan 2020
- Abandoned
- 03 Apr 2023
- Attorney of record
- James F. Keenan, Jr.
Goods and services
- Class 005 — Pharmaceuticals: medicines and pharmaceutical preparations for the treatment of diseases with a high unmet clinical need, namely, cancer, diabetes and pain related diseases; Medicines for the treatment of cancer, diabetes and pain related diseases; Anti-cancer preparations of microbial origin; Anti-cancer preparations of chemical origin; Biological preparations for the treatment of cancer, diabetes and pain related diseases
Owner
- Oblique Therapeutics AB, 413 46 Göteborg, SE
- Oblique Therapeutics AB, 413 46 Göteborg, SE
Prosecution history
- 03 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2022 — SOU EXTENSION 5 GRANTED
- 25 Aug 2022 — SOU EXTENSION 5 FILED
- 07 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2022 — SOU EXTENSION 4 GRANTED
- 25 Feb 2022 — SOU EXTENSION 4 FILED
- 25 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2021 — SOU EXTENSION 3 GRANTED
- 30 Aug 2021 — SOU EXTENSION 3 FILED
- 30 Aug 2021 — SOU TEAS EXTENSION RECEIVED